Phase 1 and Analgesic Proof-of-Concept

Lotus Clinical Research’s patient training tools and data collection methodologies result in reduced variability and improved statistical sensitivity toward the primary efficacy endpoint.

 

Multi-Day Confinement, Pharmacokinetic and CSF Collection

Lotus Clinical Research has the ability to house analgesic and surgical patients for up to 30 days in order to:

 

Located Within A 675-Bed Multispecialty Community Hospital

Lotus Clinical Research operates a 40-bed phase 1 unit located within a community hospital, providing our clients with unprecedented access to medical subspecialists and technological resources. The emergency room is 100 yards away and the hospital code team will respond to our unit conferring an additional layer of safety to our subjects.

 

Contracts Independently and Utilizes Central IRB

Although Lotus Clinical Research is located inside a hospital, it is an independent business unit which means that it can utilize a central IRB and execute contracts independently from the hospital. This results in rapid study starts that are not tied to the institutional bureaucracy typical of other hospital-based units.

 

Contemporaneous Pharmacokinetic/Pharmacodynamic Assessments

The Lotus Clinical Research phase 1 team is skilled in pharmacokinetic assessment and processing. All staff who handle blood products are IATA certified. The unit is equipped with a refrigerated centrifuge and minus 70-degree freezer.

 

Double Stopwatch Technique

Our staff has extensive experience with the double stopwatch methodology. Subjects are trained with our proprietary tools to understand the difference between perceptible and meaningful relief.